Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
CAS Number:
[906068-56-2]
Target:
TGN1412 , TAB-08 , TABO8
* VAT and and shipping costs not included. Errors and price changes excepted